| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:2065-2075.)
© 2007 American Heart Association, Inc.
Vascular Medicine |
From the Departments of Medicine (S.K., G.K.S., J.S., M.Y., P.L., C.S., Y.Z., G.S.) and Pathology (V.L., P.D.), Brigham and Womens Hospital and Harvard Medical School, Boston, Mass; Department of Medicine, Dana Farber Cancer Institute and Harvard Medical School (X.Y.), Boston, Mass; and Institut für Molekulare Medizin und Zellforschung, Albert-Ludwigs-Universität Freiburg (C.P.), Freiburg, Germany.
Correspondence to Guo-Ping Shi, DSc, Cardiovascular Medicine, NRB-7, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail gshi{at}rics.bwh.harvard.edu
Received August 1, 2006; accepted January 30, 2007.
Background Remodeling of the arterial extracellular matrix participates importantly in atherogenesis and plaque complication. Increased expression of the elastinolytic and collagenolytic enzyme cathepsin L (Cat L) in human atherosclerotic lesions suggests its participation in these processes, a hypothesis tested here in mice.
Methods and Results We generated Cat L and low-density lipoprotein receptor (LDLr) double-deficient (LDLr/Cat L/) mice by crossbreeding Cat Lnull (Cat L/) and LDLr-deficient (LDLr/) mice. After 12 and 26 weeks of a Western diet, LDLr/Cat L/ mice had significantly smaller atherosclerotic lesions and lipid cores compared with littermate control LDLr/Cat L+/ and LDLr/Cat L+/+ mice. In addition, lesions from the compound mutant mice showed significantly reduced levels of collagen, medial elastin degradation, CD4+ T cells, macrophages, and smooth muscle cells. Mechanistic studies showed that Cat L contributes to the degradation of extracellular matrix elastin and collagen by aortic smooth muscle cells. Smooth muscle cells from LDLr/Cat L/ mice or those treated with a Cat Lselective inhibitor demonstrated significantly less degradation of elastin and collagen and delayed transmigration through elastin in vitro. Cat L deficiency also significantly impaired monocyte and T-lymphocyte transmigration through a collagen matrix in vitro, suggesting that blood-borne leukocyte penetration through the arterial basement membrane requires Cat L. Cysteine protease active site labeling demonstrated that Cat L deficiency did not affect the activity of other atherosclerosis-associated cathepsins in aortic smooth muscle cells and monocytes.
Conclusions Cat L directly participates in atherosclerosis by degrading elastin and collagen and regulates blood-borne leukocyte transmigration and lesion progression.
This article has been cited by other articles:
![]() |
F. K. Swirski, R. Weissleder, and M. J. Pittet Heterogeneous In Vivo Behavior of Monocyte Subsets in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1424 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Cailhier, I. Sirois, P. Laplante, S. Lepage, M.-A. Raymond, N. Brassard, A. Prat, R. V. Iozzo, A. V. Pshezhetsky, and M.-J. Hebert Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis J. Biol. Chem., October 3, 2008; 283(40): 27220 - 27229. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |